Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets - Hillery,C.A.; Mancuso,D.J.; Evan,S.J. (Blood, 1998)